2025 BSMA US Summit
Join our Catalent Clinical Supply experts at the 17th Annual BSMA Summit! This year’s theme focuses on building resilience and sustainability in the bio-pharma supply chain while ensuring affordable healthcare. Leaders in Clinical and Commercial Supply, Operations, Transportation, Logistics, and Digital Transformation will gather to share insights and drive industry advancements.
Schedule a meeting with us to discuss your next clinical supply project!
Date: March 26-27, 2025
Location: Foster City, CA
Booth: #9
JOIN US!
Catalent is delighted to be the official sponsor of the BSMA US Summit Networking Cocktail Party! Don’t miss out on this lively event and meet industry peers over food, drinks, music, and games.
6:00 pm PT, March 27, 2025
SPEAKING SESSIONS
BEST PRACTICES FOR COMMERCIALIZATION OF DRUGS: THE NEW PRODUCT INTRODUCTION PARADIGM
2:45 pm PT, March 26, 2025
The launch of a drug in the marketplace involves getting approval from FDA, transitioning from Clinical Supply to Commercialization, self or distribution with a strategic partner, being watchful of pharmacovigilance, and having all the required systems, people, and services in place with reliability. Lessons learned from war horrors will be discussed and proven practices recommended to optimize the successful acceptance of the product by consumers.
PANEL:
Matt Blume, Vice President, Operations, Catalent
Charles Enriquez, Sr. Director, Supply Chain Business Owner, Allogene
Mike Ragone, Sr. Director Supply Chain, Vaxcyte
Adam Tamanini, Sr. Manager, Services Product, North America, World Courier (Cencora)
Moderator: Arun Cavale, CEO, NexInfo
ADVANCING FLEXIBLE CLINICAL SUPPLY WITH DEMAND-LED SOLUTIONS
11:00 am PT, March 26, 2025
Speaker: Kate Carey, Regional Director, US, Strategic Supply Solutions
Catalent
WHAT WILL YOU LEARN?
- Evolution of Clinical Supply Models: Technological, industrial and life science trends that continue to impact and shape the clinical supply chain
- Comparison of Clinical Supply Models: What are the current clinical supply models? How are they differentiated, and which models work best in which scenarios?
- Attributes and Benefits of a Demand-Led Model: Key aspects to consider when establishing the model to provide reduced lead times, less waste and lower costs.
- Flexibility within a Demand-Led Model – the Hybrid Approach: How can switching the demand-led model on and off at key points within the study maximize efficiencies and enable economies of scale throughout the supply chain?
- Processes, Systems and Tools to Enable a Demand-Led Model: How to pool supplies at a program level, aggregate demand at a hub level and set up IRT systems to support inventory management and order oversight across hybrid supply chains
- Demand-Led Supply in Action: An interactive case study comparing demand-led with traditional supply chains using real life examples, including calculating costs and reviewing outcomes, both quantitively and qualitatively
ABOUT CATALENT
Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) whose mission is to develop, manufacture, and supply products that help people live better and healthier lives. Catalent is dedicated to delivering unparalleled service to pharma, biotech, and consumer health customers, supporting product development, launch, and full life-cycle supply. With time-tested experience in development sciences, delivery technologies, and multi-modality manufacturing, Catalent supports the acceleration of development programs and the launch of more than a hundred new products every year. Powered by thousands of scientists and technicians and the latest technology platforms at more than 40 global sites, Catalent supplies billions of doses of life-enhancing and life-saving treatments for patients annually. www.catalent.com.
